Tau dephosphorylation and microfilaments disruption are upstream events of the anti-proliferative effects of DADS in SH-SY5Y cells

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 3, 2010, Pages 564-577

  Aquilano, Katia ^a   Vigilanza, Paola ^a   Filomeni, Giuseppe ^a   Rotilio, Giuseppe ^a,b   Ciriolo, Maria R ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Diallyl disulphide; Garlic; Microfilaments; Microtubules; Tau

Indexed keywords

ALLYL COMPOUND; COPPER ZINC SUPEROXIDE DISMUTASE; DIALLYL DISULFIDE; DISULFIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TAU PROTEIN;

ARTICLE; CELL PROLIFERATION; CYTOSKELETON; DRUG EFFECT; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; METABOLISM; MICROFILAMENT; MICROTUBULE; NEUROBLASTOMA; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

ALLYL COMPOUNDS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOSKELETON; DISULFIDES; HELA CELLS; HUMANS; MICROFILAMENTS; MICROSCOPY, FLUORESCENCE; MICROTUBULES; NEUROBLASTOMA; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES; TAU PROTEINS;

ALLIUM SATIVUM;

EID: 77953512362     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00588.x     Document Type: Article

References (65)

1. Shukla Y, Kalra N. Cancer chemoprevention with garlic and its constituents. Cancer Lett. 2007, 247:167-81.
2. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr. 2006, 136:736S-40S.
3. Block E. The chemistry of garlic and onions. Sci Am. 1985, 252:114-9.
4. Herman-Antosiewicz A, Powolny AA, Singh SV. Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacol Sin. 2007, 28:1355-64.
5. Filomeni G, Aquilano K, Rotilio G. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res. 2003, 63:5940-9.
6. Aquilano K, Filomeni G, Baldelli S. Neuronal nitric oxide synthase protects neuroblastoma cells from oxidative stress mediated by garlic derivatives. J Neurochem. 2007, 101:1327-37.
7. Filomeni G, Aquilano K, Rotilio G. Glutathione-related systems and modulation of extracellular signal-regulated kinases are involved in the resistance of AGS adenocarcinoma gastric cells to diallyl disulfide-induced apoptosis. Cancer Res. 2005, 65:11735-42.
8. Dalle-Donne I, Rossi R, Milzani A. The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic Biol Med. 2001, 31:1624-32.
9. Dalle-Donne I, Rossi R, Giustarini D. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med. 2002, 32:927-37.
10. Kang KW, Lee SJ, Kim SG. Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal. 2005, 7:1664-73.
11. Boutte AM, Woltjer RL, Zimmerman LJ. Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease. FASEB J. 2006, 20:1473-83.
12. Mirabelli F, Salis A, Perotti M. Alterations of surface morphology caused by the metabolism of menadione in mammalian cells are associated with the oxidation of critical sulfhydryl groups in cytoskeletal proteins. Biochem Pharmacol. 1988, 37:3423-7.
13. Rokutan K, Johnston RB, Kawai K. Oxidative stress induces S-thiolation of specific proteins in cultured gastric mucosal cells. Am J Physiol. 1994, 266:G247-54.
14. Caprari P, Bozzi A, Malorni W. Junctional sites of erythrocyte skeletal proteins are specific targets of tert-butylhydroperoxide oxidative damage. Chem Biol Interact. 1995, 94:243-58.
15. Banan A, Zhang Y, Losurdo J. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut. 2000, 46:830-7.
16. Dourdin N, Bhatt AK, Dutt P. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem. 2001, 276:48382-8.
17. van Engeland M, Kuijpers HJ, Ramaekers FC. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res. 1997, 235:421-30.
18. Sanchez-Alcazar JA, Rodriguez-Hernandez A, Cordero MD. The apoptotic microtubule network preserves plasma membrane integrity during the execution phase of apoptosis. Apoptosis. 2007, 12:1195-208.
19. Brown SB, Bailey K, Savill J. Actin is cleaved during constitutive apoptosis. Biochem J. 1997, 323:233-7.
20. Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene. 1999, 18:2423-30.
21. Marceau N, Schutte B, Gilbert S. Dual roles of intermediate filaments in apoptosis. Exp Cell Res. 2007, 313:2265-81.
22. Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA. 2003, 100:2432-7.
23. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007, 47:89-116.
24. Woodring PJ, Hunter T, Wang JY. Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci. 2003, 116:2613-26.
25. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001, 24:1121-59.
26. Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol. 1998, 10:123-30.
27. Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents. 2005, 5:65-71.
28. Stehn JR, Schevzov G, O'Neill GM. Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy. Curr Cancer Drug Targets. 2006, 6:245-56.
29. De Martino A, Filomeni G, Aquilano K. Effects of water garlic extracts on cell cycle and viability of HepG2 hepatoma cells. J Nutr Biochem. 2006, 17:742-9.
30. Xiao D, Pinto JT, Soh JW. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH-terminal kinase 1 activation. Cancer Res. 2003, 63:6825-37.
31. Xiao D, Pinto JT, Gundersen GG. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol Cancer Ther. 2005, 4:1388-98.
32. Hosono T, Fukao T, Ogihara J. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. J Biol Chem. 2005, 280:41487-93.
33. Prager-Khoutorsky M, Goncharov I, Rabinkov A. Allicin inhibits cell polarization, migration and division via its direct effect on microtubules. Cell Motil Cytoskeleton. 2007, 64:321-37.
34. Hosono T, Hosono-Fukao T, Inada K. Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells. Carcinogenesis. 2008, 29:1400-6.
35. Sela U, Ganor S, Hecht I. Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression. Immunology. 2004, 111:391-9.
36. Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous system. J Cell Biol. 1985, 101:1371-8.
37. Fulga TA, Elson-Schwab I, Khurana V. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol. 2007, 9:139-48.
38. Canu N, Dus L, Barbato C. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci. 1998, 18:7061-74.
39. Rametti A, Esclaire F, Yardin C. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis. J Biol Chem. 2004, 279:54518-28.
40. Merrick SE, Demoise DC, Lee VM. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J Biol Chem. 1996, 271:5589-94.
41. Davis DR, Brion JP, Couck AM. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J. 1995, 309:941-9.
42. Mattson MP. Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons. Brain Res. 1992, 582:107-18.
43. Carri MT, Ferri A, Battistoni A. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 1997, 414:365-8.
44. Aquilano K, Rotilio G, Ciriolo MR. Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS. J Neurochem. 2003, 85:1324-35.
45. Vigilanza P, Aquilano K, Rotilio G. Transient cytoskeletal alterations after SOD1 depletion in neuroblastoma cells. Cell Mol Life Sci. 2008, 65:991-1004.
46. Lowry OH, Rosebrough NJ, Farr AL. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193:265-75.
47. Gamblin TC, Chen F, Zambrano A. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA. 2003, 100:10032-7.
48. Morris EJ, Evason K, Wiand C. Misdirected vimentin messenger RNA alters cell morphology and motility. J Cell Sci. 2000, 113:2433-43.
49. Nicoletti I, Migliorati G, Pagliacci MC. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991, 139:271-9.
50. Basu A, Haldar S. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. Int J Oncol. 1998, 13:659-64.
51. Pathan N, Aime-Sempe C, Kitada S. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia. 2001, 3:550-9.
52. Johnson GV. Tau phosphorylation and proteolysis: insights and perspectives. J Alzheimers Dis. 2006, 9:243-50.
53. Tanaka T, Zhong J, Iqbal K. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Lett. 1998, 426:248-54.
54. Tian Q, Wang J. Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals. 2002, 11:262-9.
55. Davis DR, Anderton BH, Brion JP. Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures. J Neurochem. 1997, 68:1590-7.
56. Galas MC, Dourlen P, Begard S. The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem. 2006, 281:19296-304.
57. Zambrano CA, Egana JT, Nunez MT. Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1. Free Radic Biol Med. 2004, 36:1393-402.
58. Sommer D, Coleman S, Swanson SA. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch Biochem Biophys. 2002, 404:271-8.
59. Aggen JB, Nairn AC, Chamberlin R. Regulation of protein phosphatase-1. Chem Biol. 2000, 7:R13-23.
60. Agarwal-Mawal A, Paudel HK. Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J Biol Chem. 2001, 276:23712-8.
61. Li M, Ciu JR, Ye Y. Antitumor activity of Z-ajoene, a natural compound purified from garlic: antimitotic and microtubule-interaction properties. Carcinogenesis. 2002, 23:573-9.
62. Dalle-Donne I, Rossi R, Giustarini D. Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med. 2001, 31:1075-83.
63. Johnson GV, Jenkins SM. Tau protein in normal and Alzheimer's disease brain. J Alzheimers Dis. 1999, 1:307-28.
64. Avila J, Lucas JJ, Perez M. Role of tau protein in both physiological and pathological conditions. Physiol Rev. 2004, 84:361-84.
65. Mills JC, Lee VM, Pittman RN. Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J Cell Sci. 1998, 111:625-36.